Hepatotoxicity and Drug-Induced Liver Injury

Hepatotoxicity occurs when toxins or drugs cause liver damage, which can lead to liver failure or chronic liver disease. Drug-induced liver injury (DILI) is a leading cause of liver transplantation. Research focuses on identifying early biomarkers, understanding metabolic pathways that contribute to toxicity, and developing safer pharmaceuticals. Improved preclinical screening and personalized medicine approaches help predict which patients are at higher risk for DILI, improving the safety of new drugs and treatments.

    Related Conference of Hepatotoxicity and Drug-Induced Liver Injury

    February 19-20, 2026

    6th World Congress on Climate Change and Ecosystem

    Paris, France
    May 14-15, 2026

    14th World Conference on Climate Change

    London, UK
    June 22-23, 2026

    8th Global Summit on Environmental Health

    London, UK
    June 29-30, 2026

    13th International Conference on Recycling & Waste Management

    Aix-en-Provence, France
    July 09-10, 2026

    21st World Bioenergy Congress and Expo

    Zurich, Switzerland
    July 27-28, 2026

    18th World Congress and Expo on Recycling

    Rome, Italy
    July 30-31, 2026

    11th Global Summit on Climate Change

    Paris, France
    August 10-11, 2026

    14th World Congress and Expo on Green Energy

    Berlin, Germany
    September 14-15, 2026

    20th Global Summit and Expo on Biomass and Bioenergy

    Rome, Italy
    September 14-15, 2026

    20th World Congress on Biofuels and Bioenergy

    Rome, Italy
    October 29-30, 2026

    14th International Conference on Green Energy

    Paris, France
    November 19-20, 2026

    15th World Conference on Earth Science & Geology

    Dubai, UAE

    Hepatotoxicity and Drug-Induced Liver Injury Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in